Dennis Langer, Director at Dicerna Pharma, holds 77.04K shares in Dicerna Pharma (Ticker: DRNA), holds 0.00 shares in Pernix Therapeutics (Ticker: PTXTQ), holds ― shares in Eterna Therapeutics (Ticker: ERNA).
Dennis Langer latest transaction was an Uninformative Sell of $613.46K.
What was Dennis Langer's most profitable transaction?
Dennis Langer’s most profitable transaction was an Informative Sell of MYGN stock on June 1, 2018. The return on the trade was 37.20%.
What is Dennis Langer's role in Dicerna Pharma?
Dennis Langer's role in Dicerna Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.